ArticleFrontiers in neurology2025
Global, regional, and national burden of headache disorders, 1990-2021, and projections to 2050: a comprehensive analysis of the global burden of disease study 2021.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Review
- Profile of migraine patients in Middle East and North Africa (MENA) region: a multi-center study.The journal of headache and pain · 2026Article
- Geriatric Migraine, Geroscience, and Sustainable Development Goals: Bridging Clinical Complexity and Public Health Priorities.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Headache disorders, including migraines and tension-type headaches, are prevalent and debilitating conditions that affect millions of people worldwide. And this analysis aims to inform evidence-based interventions and policies for alleviating the burden of headache disorders on individuals and societies. Methods: We analyzed headache data from the Global Burden of Disease Study 2021 report, examining the prevalence, incidence, and disability-adjusted life years across 204 countries and territories over 32 years. The data were stratified according to age, sex, year, geographical region, and socio-demographic Index (SDI). We employed the estimated average percentage change calculation to assess the temporal trends of these indicators. A detailed analysis of health inequities was conducted using decomposition analysis, the pyramid model, slope index, and concentration index. The Bayesian Age-Period-Cohort model was used to forecast the disease burden over the next 26 years. Results: By 2021, the global incidence of headache disorders was estimated to be 809.2 million, with tension-type headaches being the most prevalent. Age-standardized incidence rates, prevalence rates, and DALYs have exhibited an overall upward trend since 1990. The health inequality analysis revealed a diminishing disparity in the burden of headache disorders across countries with varying SDI scores. Predictions indicate a continuous increase in headache disorders, potentially reaching over 3.5 billion by 2050 based on current trends. Conclusion: The burden of headache disorders is increasing, with important implications for global health and the economy. The rising predictions highlight the potential need for targeted public health strategies and interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.